Behavioural Neurology

Behavioural Neurology / 2018 / Article

Research Article | Open Access

Volume 2018 |Article ID 3954101 |

Xiaojing Long, Chunxiang Jiang, Lijuan Zhang, "Morphological Biomarker Differentiating MCI Converters from Nonconverters: Longitudinal Evidence Based on Hemispheric Asymmetry", Behavioural Neurology, vol. 2018, Article ID 3954101, 9 pages, 2018.

Morphological Biomarker Differentiating MCI Converters from Nonconverters: Longitudinal Evidence Based on Hemispheric Asymmetry

Academic Editor: Hwee L. Lee
Received09 Aug 2017
Revised11 Dec 2017
Accepted03 Jan 2018
Published19 Mar 2018


Identifying subjects with mild cognitive impairment (MCI) who may probably progress to Alzheimer’s disease (AD) is important for better understanding the disease mechanisms and facilitating early treatments. In addition to the direct volumetric and thickness measurement based on high-resolution magnetic resonance imaging (MRI), hemispheric asymmetry could be a potential index to detect morphological variations in MCI patients with a high risk of conversion to AD. The present study collected a set of longitudinal MRI data from 53 MCI converters and nonconverters and investigated the asymmetry differences between groups. Asymmetry variation was observed in the medial temporal lobe, especially in the entorhinal cortex, between converters and nonconverters 3 years before the former developed AD. The proposed asymmetry analysis was observed to be sensitive to detect morphological changes between groups as compared to the methods of voxel-based morphometry (VBM) and thickness measurement. Hemispheric asymmetry in specific brain regions as a neuroimaging biomarker can provide helpful information for prediction of MCI conversion.

1. Introduction

Alzheimer’s disease (AD) is the most common form of dementia with a rapidly rising prevalence worldwide as a result of global aging. There are currently no treatments available that can provide a cure for AD. However, major scientific advances in genetical, biochemical, cell biological, and neuroscience studies over the last decades offer hope that effective therapeutic intervention is likely to be developed and to largely change the life quality of AD patients if the disease is detected prior to the onset of overt symptoms and signs [1].

Mild cognitive impairment (MCI) manifests as an intermediate stage between the expected cognitive decline in normal aging and the more serious decline in age-associated dementia [2]. It causes a slight but measurable decline in cognitive abilities; nevertheless, it does not significantly impact patients’ daily functioning. People with MCI may be three to five times more likely to develop AD or other types of dementia relative to those without MCI [3]. However, not all people with MCI get worse and some even get better. Identifying the subjects with MCI who will end up with AD (referred to as “MCI converters”) is of great importance in terms of better understanding the disease mechanisms and initiating early treatments for the patients.

Combined with the clinical tests of cognition or behaviors, biomarkers from structural and functional magnetic resonance imaging (MRI) have been employed for the disease characterization. Volumetric analysis for the whole brain, hippocampus, and ventricles has demonstrated different atrophy or enlargement rate in annual change between MCI converters and subjects with stable MCI with a larger tissue loss in MCI converters [48]. Voxel-based morphometry (VBM) and tensor-based morphometry (TBM), which allow 3D mapping of focal differences in brain anatomy, have detected significantly faster tissue reduction in the medial temporal lobe, posterior cingulate gyrus, and hippocampus [912]. Surface-based analysis which provides insight into the cortical morphological variations has identified shape differences between MCI converters and nonconverters in the inferior parietal cortex and both lateral and medial temporal cortices, especially in the entorhinal cortex [11, 13, 14].

Previous studies have also demonstrated asymmetrical cerebral atrophy in AD and MCI. Barnes et al. [15] and Shi et al. [16] have, respectively, reported asymmetric atrophy in the hippocampus. Derflinger et al. have found that lobar asymmetry of the temporal, parietal, and occipital lobes is different from healthy controls to AD patients [17]. In our earlier study, significant asymmetry alterations in limbic structures were identified among healthy elderly, MCI converters, and AD patients [18], suggesting that structural asymmetry difference may embed biomarkers that distinguish MCI converters from nonconverters.

In this study, a multivariate model that collectively takes into account the effects of multiple morphological variables, including the cortical thickness, surface area, and curvature index, was used to investigate the hemispheric asymmetry on a longitudinal database to distinguish MCI converters from nonconverters. Images from 5 visits (1 baseline and 4 follow-ups) were examined to determine the earliest time point at which converters can be differentiated from nonconverters. The results were compared to those of the VBM and vertex-based thickness analyses for a sensitivity evaluation among different methods in discriminating patients of a high risk.

2. Materials and Methods

2.1. Subjects and MR Scanning

Data of 26 MCI converters (15 males, aged 73.35 ± 6.71 years) and 27 nonconverters (21 males, aged 73.01 ± 7.47 years) was retrieved from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (, phases 1, Go, and 2. ADNI is the result of efforts of many investigators from a broad range of academic institutions and private corporations, and subjects have been recruited from over 50 sites across the US and Canada. The ADNI study was approved by the IRB of all participating sites. All subjects and, if applicable, their legal representatives gave written informed consent prior to the collection of clinical, genetic, and imaging data. The dataset follows the rigor establishment with careful quality control, detailed documentation, and full anonymization prior to data analysis. Approval for public sharing of the anonymized data was obtained.

The subjects are right handed and had taken at least five follow-up visits with MR scanning at an interval of roughly one year. The MCI nonconverters were not diagnosed with probable AD in any of the visits. The MCI converters remained in the MCI category for at least 3 consecutive visits before conversion to AD and maintained mild AD status for at least 2 consecutive visits after conversion.

High-resolution T1-weighted images (T1WI) were obtained using the MP-RAGE sequence with typical parameters of TR = 6.5~9.5 ms (GE)/2300~3000 ms (SIEMENS), TE = 3.0~4.0 ms, FA = 8°, FOV = 256 × 256, and in-plane resolution = 1 mm × 1 mm × 1.2 mm. The ADNI MRI core has established strict guidelines and procedures to ensure similar image qualities across sites and platforms over time. A customized MP-RAGE pulse sequence was developed for the GE platform to minimize vendor-to-vendor differences [19].

2.2. Hemispheric Asymmetry Analysis

Data were processed with the “recon-all” pipeline of FreeSurfer software (Version 5.0.0, Images were first intensity normalized, skull stripped, aligned to a standard space, and segmented into gray matter (GM), white matter (WM), and cerebrospinal fluid (CSF). The cortical surface and WM surface were constructed, inflated, topologically corrected, and projected to the standard spherical coordinate system defined by the FreeSurfer brain atlas. Then, the cerebral cortex was automatically divided into 34 gyral-based regions of interest (ROI) [2022]. The surface area, mean curvature index, and cortical thickness were calculated on each ROI of each hemisphere. ROI-wise multivariate analysis of covariance (MANCOVA) was performed to test the compositive morphological differences between the left and right hemispheres for each group. For each ROI, the surface area, curvature index, and cortical thickness were introduced as collective response variables with gender and age as covariates. Regions with significant asymmetry were identified as . Correction was performed in multiple comparison procedures to control the false discovery rate (FDR) at 0.05. values were mapped onto the cortical surface of the left hemisphere of FreeSurfer fsaverage template for visualization.

The asymmetry index (AI) of each ROI for each subject was defined as and the group asymmetry index of each ROI was defined as where denotes the ith variable of the left hemisphere for the jth subject and denotes the ith variable of the right hemisphere for the jth subject, denotes an average of x across the group. AI > 0 indicates leftward lateralization, and AI < 0 indicates rightward lateralization. Between-group difference for a specific region was computed using the two-sample t-test on the asymmetry index with gender and age effects being regressed out. The significance level was set at 0.05.

2.3. Voxel-Based Morphometry (VBM)

Cross-sectional VBM analysis was performed for each time point. SPM8 was used for voxel-based morphometry ( Images from all groups were first roughly aligned via a rigid body transformation and segmented into gray matter, white matter, and CSF [23]. The template image used for spatial normalization was created by averaging across the study cohort. The segmented gray matter tissue map was aligned from the individual space to the template space, scaled by the Jacobian field, and smoothed with the full width at the half maximum (FWHM) of 10 mm, followed by a modulation step to correct for volume change [24]. A design matrix was constructed, and the general linear model (GLM) was fitted to the data with gender and age as covariates. Voxel-wise parametric statistical tests were performed to compare the GM differences between MCI converters and nonconverters. Corrections for multiple comparisons were conducted using the theory of Gaussian random fields (GRF) as the preprocessed images were spatially smoothed and voxels were correlated with their neighbors. Significant voxels with corrected were displayed on the MNI brain template for visualization.

2.4. Vertex-Based Thickness Analysis

Cross-sectional thickness analysis was performed for each time point. FreeSurfer software (Version 5.0.0, was used for image processing and group analysis. Processing steps were conducted as introduced in hemispheric asymmetry analysis. Surface-based normalization was computed to map thickness data of each subject onto a common group space that allows the thickness to be compared across subjects at homologous points on the cortex. The thickness is then smoothed with FWHM = 10 mm, and the GLM was fitted to the data with gender and age as covariates (FreeSurfer_Qdec). Vertex-wise statistical test was performed to compare the thickness differences between converters and nonconverters for each hemisphere. Corrections for multiple comparisons were conducted to control the FDR at 0.05. The corrected significance map with was finally overlapped onto the fsaverage brain template surface for visualization.

3. Results

No significant difference was found in age and MMSE scores at the baseline visit between converters and nonconverters (Table 1).

GroupsNumber of subjects (m/f)AgeAPOE A1APOE A2MMSE score

Converters26 (15/11)73.35 ± 6.713.19 ± 0.493.73 ± 0.4527.19 ± 2.05
Nonconverters27 (21/6)73.01 ± 7.472.93 ± 0.473.41 ± 0.528.07 ± 1.33

3.1. Hemispheric Asymmetry Analysis

Both MCI converters and nonconverters featured leftward lateralization in the transverse temporal gyrus, as well as rightward lateralization in the lateral orbitofrontal gyrus and inferior parietal lobule (Figure 1). Different asymmetry patterns were identified in the medial side of the brain, specifically located in the limbic system including the anterior cingulate cortex and the entorhinal cortex. Leftward lateralization was observed in the entorhinal cortex in MCI nonconverters from baseline to the last visit, as well as in the rostral anterior cingulate gyrus in converters during all visits. Rightward lateralization in the caudal anterior cingulate gyrus was detected at the baseline and the 2nd and 4th follow-up visits in MCI nonconverters.

Calculation of the group asymmetry index of each ROI at all visits showed that a certain of the 34 cortical regions that underwent asymmetry decreases with the mean asymmetry index trending towards zero over time (Figure 2). Those regions included the language-related areas such as the banks of the superior temporal sulcus, caudal middle frontal gyrus, inferior parietal lobule, and pars triangularis, as well as the memory-related areas such as the entorhinal cortex and parahippocampal gyrus (Figure 3). MCI converters exhibited a more notable decreasing trend than nonconverters, especially in areas of the banks of the superior temporal sulcus, the entorhinal cortex, and the pars triangularis. In some other regions, including the posterior cingulate, superior parietal lobule, fusiform, precentral gyrus, and precuneus, group asymmetry indices varied slightly over 5 visits and the values approximately equal zero (Figure 2). Two-sample t-test analysis demonstrated that significant between-group differences were found in the entorhinal cortex, frontal pole, and rostral anterior cingulate. No significant between-group difference was observed in other ROIs.

3.2. Voxel-Based Morphometry

The MCI converters were observed with greater tissue shrinkage from the baseline scanning to follow-ups in the bilateral hippocampus, amygdala, parahippocampal gyrus, and entorhinal cortex, compared with nonconverters (Figure 4). Significant volume reduction in converters was also observed in the precentral gyrus, superior frontal gyrus, middle temporal gyrus, and nucleus accumbens at the first two visits.

3.3. Vertex-Based Thickness Analysis

No significant thickness difference was found between the MCI converters and nonconverters in the first two visits. From 1 year before the converters progressed to AD, we observed thinner cortices mainly located in the bilateral occipital and temporal lobes, specifically in the lateral occipital gyrus, entorhinal cortex, temporal pole, and cingulate gyrus (Figure 5).

4. Discussion

In this study, cross-sectional hemispheric asymmetry analysis as well as VBM and vertex-based thickness analyses was performed for different time points to identify regions that could discriminate MCI converters from nonconverters and how early they could work for differentiation. The results demonstrated that asymmetry and VBM analyses were sensitive to morphological differences between the two cohorts, which can be used to dissociate MCI converters 3 years prior to conversion.

VBM and vertex-based thickness analyses have been commonly used to capture the dynamics of gray matter atrophy and cortical thickness reduction in AD and MCI patients [12, 25, 26]. Chételat et al. have found significantly greater gray matter loss in MCI converters relative to nonconverters 18 months prior to their conversion in a longitudinal VBM study [12]. Risacher et al. have reported that MCI converters demonstrated higher atrophy progression with more severe reduction in gray matter density from baseline to 1 year [25]. They have also shown that annual thickness changes in MCI converters were significantly greater than those in nonconverters. In this work, we applied both VBM and thickness analyses along with the proposed asymmetry method on the same set of longitudinal data to detect the morphological differences between MCI converters and nonconverters. The VBM study identified remarkable volume reduction in MCI converters 3 years before they progressed to AD, whereas vertex-based thickness analysis only detected significant cortical thinning in converters 1 year before conversion. Hutton et al. showed that thickness analysis provided a more sensitive measure of age-associated decline in gray matter compared with VBM [27]. However, the present study demonstrated that VBM works better in differentiating slight variation between age-matched brains, which may be attributable to the difference in methodology that thickness analysis selectively investigates cortical thickness while VBM provides a mixed measure of gray matter including cortical surface area or cortical folding, as well as cortical thickness [27]. The proposed asymmetry method has also shown great power of sensitively detecting group differences. In our previous study, we have found that multivariate analysis that combined multiple morphological measures including the surface area, curvature index, and cortical thickness was more sensitive in picking up subtle alterations of hemispheric asymmetries than each individual measure [18]. None of the individual measures have acted as the pivotal contributor [28], but the compositive effect of all measures enhanced the performance. Studies have illustrated that gray matter atrophy is asymmetric in AD and MCI [17, 18]. The present work showed a consistent result but further demonstrated that the asymmetric tissue shrinkage occurred at least 3 years earlier to the conversion of AD. The asymmetry alteration could be a novel and sensitive imaging marker that can distinguish MCI patients with a high risk of conversion to AD at an early time point.

Brain asymmetry is believed to be evolutionally adaptive, enabling more specialized and efficient functioning of the brain [29]. Gómez-Robles et al. have suggested that morphological asymmetry of the human brain enhances cognition compared to that of nonhuman primates [30]. Plessen et al. have assessed the correlation of cognitive performance with measures of cortical thickness asymmetry in children and adults and reported that asymmetry in cortical thickness is correlated with human cognitive function [31]. In this study, regression analysis of group asymmetry indices demonstrated a more pronounced decreasing trend from baseline to follow-up visits in MCI converters, compared with nonconverters, in the language-related and memory-related cortical regions, including the banks of the superior temporal sulcus, caudal middle frontal gyrus, inferior parietal lobule, pars triangularis, entorhinal cortex, and parahippocampal gyrus. The observation is consistent with the common understanding that AD is characterized by progressively worsening deficits in language [32] and memory [33]. Among the aforementioned cortical regions, the asymmetry indices of the entorhinal cortex, banks of the superior temporal sulcus, and pars triangularis demonstrated the sharpest decline in converters yet gentle variations in nonconverters, which agreed with our previous finding that hemispheric asymmetry was better preserved in these regions in healthy elderly and in the early stage of MCI converters but lost in AD patients [18]. Killiany et al. have reported that MRI measures of the entorhinal cortex and the banks of the superior temporal sulcus were most useful in predicting the follow-up status of MCI subjects [34]. These evidences suggested that the discriminative characteristics of the featured regions may consist not only in the volume reduction of corresponding structures but also in the imbalance of tissue atrophy. Although converters and nonconverters were both diagnosed with MCI with a degree of cognitive decline at the baseline visit, the brain morphological patterns of the two groups have differed at an earlier time point.

Asymmetry indices in the posterior cingulate gyrus, superior parietal lobule, fusiform, precentral gyrus, and precuneus smoothly ranged around zero in both MCI converters and nonconverters, indicating very mild asymmetry from baseline to follow-ups. Nevertheless, the results may arise from different situations. Regions such as the fusiform, precentral gyrus, and precuneus presented no significant asymmetry in young adults and healthy elderly [18, 35], suggesting that the absence of asymmetry may intrinsically exist and may not be affected by aging or cognition decline. However, pronounced asymmetry was observed in regions such as the posterior cingulate and superior parietal lobule in young adult brain [18, 35] while it disappeared in healthy elderly and MCI subjects, which may imply that asymmetry in these regions varies over time but is not distinctive to differentiate between healthy elderly, MCI converters, and nonconverters.

Converging evidence has demonstrated that gray matter shrinkage in prodromal AD mainly occurred in the medial temporal lobe (MTL), specifically in the hippocampus, parahippocampal gyrus, and entorhinal cortex. By measuring the hippocampal and entorhinal volume, deToledo-Morrell et al. have shown that the volumes of these two regions can well differentiate MCI converters from nonconverters, especially the right hemisphere entorhinal cortex that best predicted conversion with an accuracy of 93.5% [36]. Risacher et al. have reported that the degree of degeneration of MTL tissue was the best antecedent MRI marker of conversion, where hippocampal volume decreases were the most robust [11]. Another study has found that cortical thickness was significantly reduced in MCI within the MTL network [37]. The results showed in the present study that the MTL structures, especially the entorhinal cortex, are the best predictor to identify MCI patients with a high risk for AD which was consistent with previous findings [38]. As a system specifically important for declarative memory [39], the MTL is the first brain area to succumb to neurofibrillary tau pathology in AD [40]. Significant morphological changes in MTL, which were detected in MCI converters 3 years before they progressed to AD, could be an effective biomarker for early diagnosis or prediction of AD.

In conclusion, hemispheric asymmetry analysis identified the entorhinal cortex as a significant morphological biomarker to differentiate MCI converters from nonconverters. Asymmetry variation demonstrated the ability to identify morphological changes in MCI converters 3 years prior to conversion. Focal hemispheric asymmetry decreases progressively from an early time point of prodromal AD, which provides helpful information that facilitates the prediction of MCI conversion and the patient management in the clinical practice.

Conflicts of Interest

The authors declare that they have no conflicts of interest.


Data used in this study were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database ( The ADNI was launched in 2003 by the National Institute on Aging (NIA), the National Institute of Biomedical Imaging and Bioengineering (NIBIB), the Food and Drug Administration (FDA), private pharmaceutical companies, and nonprofit organizations, as a $60 million, 5-year public-private partnership. The primary goal of ADNI has been to test whether serial magnetic resonance imaging (MRI), positron emission tomography (PET), other biological markers, and clinical and neuropsychological assessment can be combined to measure the progression of mild cognitive impairment (MCI) and early Alzheimer’s disease (AD). For up-to-date information, see The study was partly supported by National Natural Science Foundation of China (Grant nos. 81301285 and 81371359), the Scientific Research Program of the Shenzhen Science and Technology Innovation Committee (JCYJ20150401163247205 and JCYJ20150521094519463), the Natural Science Foundation of Guangdong Province (2014A030312006), and the Key Laboratory for Magnetic Resonance and Multimodality Imaging of Guangdong Province (2014B030301013).

Supplementary Materials

The IDs of subjects used in the study were listed in the supplementary file. (Supplementary Materials)


  1. D. M. Holtzman, J. C. Morris, and A. M. Goate, “Alzheimer’s disease: the challenge of the second century,” Science Translational Medicine, vol. 3, no. 77, article 77sr1, 2011. View at: Publisher Site | Google Scholar
  2. F. Jessen, S. Wolfsgruber, B. Wiese et al., “AD dementia risk in late MCI, in early MCI, and in subjective memory impairment,” Alzheimer’s & Dementia, vol. 10, no. 1, pp. 76–83, 2014. View at: Publisher Site | Google Scholar
  3. A. M. Weinstein, C. Barton, L. Ross, J. H. Kramer, and K. Yaffe, “Treatment practices of mild cognitive impairment in California Alzheimer’s Disease Centers,” Journal of the American Geriatrics Society, vol. 57, no. 4, pp. 686–690, 2009. View at: Publisher Site | Google Scholar
  4. M. C. Evans, J. Barnes, C. Nielsen et al., “Volume changes in Alzheimer’s disease and mild cognitive impairment: cognitive associations,” European Radiology, vol. 20, no. 3, pp. 674–682, 2010. View at: Publisher Site | Google Scholar
  5. L. K. McEvoy, C. Fennema-Notestine, J. C. Roddey et al., “Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment,” Radiology, vol. 251, no. 1, pp. 195–205, 2009. View at: Publisher Site | Google Scholar
  6. C. Misra, Y. Fan, and C. Davatzikos, “Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI,” NeuroImage, vol. 44, no. 4, pp. 1415–1422, 2009. View at: Publisher Site | Google Scholar
  7. S. M. Nestor, R. Rupsingh, M. Borrie et al., “Ventricular enlargement as a possible measure of Alzheimer’s disease progression validated using the Alzheimer’s Disease Neuroimaging Initiative database,” Brain, vol. 131, no. 9, pp. 2443–2454, 2008. View at: Publisher Site | Google Scholar
  8. P. N. Wang, H. C. Liu, J. F. Lirng, K. N. Lin, and Z. A. Wu, “Accelerated hippocampal atrophy rates in stable and progressive amnestic mild cognitive impairment,” Psychiatry Research Neuroimaging, vol. 171, no. 3, pp. 221–231, 2009. View at: Publisher Site | Google Scholar
  9. A. D. Leow, I. Yanovsky, N. Parikshak et al., “Alzheimer’s Disease Neuroimaging Initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition,” NeuroImage, vol. 45, no. 3, pp. 645–655, 2009. View at: Publisher Site | Google Scholar
  10. M. A. Trivedi, A. K. Wichmann, B. M. Torgerson et al., “Structural MRI discriminates individuals with mild cognitive impairment from age-matched controls: a combined neuropsychological and voxel based morphometry study,” Alzheimer’s & Dementia, vol. 2, no. 4, pp. 296–302, 2006. View at: Publisher Site | Google Scholar
  11. S. L. Risacher, A. J. Saykin, J. D. West et al., “Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort,” Current Alzheimer Research, vol. 6, no. 4, pp. 347–361, 2009. View at: Publisher Site | Google Scholar
  12. G. Chételat, B. Landeau, F. Eustache et al., “Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study,” NeuroImage, vol. 27, no. 4, pp. 934–946, 2005. View at: Publisher Site | Google Scholar
  13. Y. Cui, B. Liu, S. Luo et al., “Identification of conversion from mild cognitive impairment to Alzheimer’s disease using multivariate predictors,” PLoS One, vol. 6, no. 7, article e21896, 2011. View at: Publisher Site | Google Scholar
  14. E. Lebed, A. Trouvé, and M. F. Beg, “Cortical thickness analysis in Alzheimer’s onset,” Alzheimer's & Dementia, vol. 8, no. 4, pp. P157–P158, 2012. View at: Publisher Site | Google Scholar
  15. J. Barnes, R. I. Scahill, J. M. Schott, C. Frost, M. N. Rossor, and N. C. Fox, “Does Alzheimer’s disease affect hippocampal asymmetry? Evidence from a cross-sectional and longitudinal volumetric MRI study,” Dementia and Geriatric Cognitive Disorders, vol. 19, no. 5-6, pp. 338–344, 2005. View at: Publisher Site | Google Scholar
  16. F. Shi, B. Liu, Y. Zhou, C. Yu, and T. Jiang, “Hippocampal volume and asymmetry in mild cognitive impairment and Alzheimer’s disease: meta-analyses of MRI studies,” Hippocampus, vol. 19, no. 11, pp. 1055–1064, 2009. View at: Publisher Site | Google Scholar
  17. S. Derflinger, C. Sorg, C. Gaser et al., “Grey-matter atrophy in Alzheimer’s disease is asymmetric but not lateralized,” Journal of Alzheimer's Disease, vol. 25, no. 2, pp. 347–357, 2011. View at: Google Scholar
  18. X. Long, L. Zhang, W. Liao, C. Jiang, B. Qiu, and The Alzheimer’s Disease Neuroimaging Initiative, “Distinct laterality alterations distinguish mild cognitive impairment and Alzheimer’s disease from healthy aging: statistical parametric mapping with high resolution MRI,” Human Brain Mapping, vol. 34, no. 12, pp. 3400–3410, 2013. View at: Publisher Site | Google Scholar
  19. C. R. Jack Jr., M. A. Bernstein, N. C. Fox et al., “The Alzheimer’s Disease Neuroimaging Initiative (ADNI): MRI methods,” Journal of Magnetic Resonance Imaging, vol. 27, no. 4, pp. 685–691, 2008. View at: Publisher Site | Google Scholar
  20. A. Dale, B. Fischl, and M. Sereno, “Cortical surface-based analysis: I. Segmentation and surface reconstruction,” NeuroImage, vol. 9, no. 2, pp. 179–194, 1999. View at: Publisher Site | Google Scholar
  21. A. Dale and M. Sereno, “Improved localizadon of cortical activity by combining EEG and MEG with MRI cortical surface reconstruction: a linear approach,” Journal of Cognitive Neuroscience, vol. 5, no. 2, pp. 162–176, 1993. View at: Publisher Site | Google Scholar
  22. B. Fischl, M. Sereno, and A. Dale, “Cortical surface-based analysis: II: inflation, flatting, and a surface-based coordinate system,” NeuroImage, vol. 9, no. 2, pp. 195–207, 1999. View at: Publisher Site | Google Scholar
  23. J. Ashburner and K. J. Friston, “Voxel-based morphometry—the methods,” NeuroImage, vol. 11, no. 6, pp. 805–821, 2000. View at: Publisher Site | Google Scholar
  24. C. D. Good, I. S. Johnsrude, J. Ashburner, R. N. A. Henson, K. J. Friston, and R. S. J. Frackowiak, “A voxel-based morphometric study of ageing in 465 normal adult human brains,” NeuroImage, vol. 14, no. 1, pp. 21–36, 2001. View at: Publisher Site | Google Scholar
  25. S. L. Risacher, L. Shen, J. D. West et al., “Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort,” Neurobiology of Aging, vol. 31, no. 8, pp. 1401–1418, 2010. View at: Publisher Site | Google Scholar
  26. M. Bozzali, M. Filippi, G. Magnani et al., “The contribution of voxel-based morphometry in staging patients with mild cognitive impairment,” Neurology, vol. 67, no. 3, pp. 453–460, 2006. View at: Publisher Site | Google Scholar
  27. C. Hutton, B. Draganski, J. Ashburner, and N. Weiskopf, “A comparison between voxel-based cortical thickness and voxel-based morphometry in normal aging,” NeuroImage, vol. 48, no. 2, pp. 371–380, 2009. View at: Publisher Site | Google Scholar
  28. W. Liao, X. Long, C. Jiang et al., “Discerning mild cognitive impairment and Alzheimer disease from normal aging. Morphologic characterization based on univariate and multivariate models,” Academic Radiology, vol. 21, no. 5, pp. 597–604, 2014. View at: Publisher Site | Google Scholar
  29. A. W. Toga and P. M. Thompson, “Mapping brain asymmetry,” Nature Reviews Neuroscience, vol. 4, no. 1, pp. 37–48, 2003. View at: Publisher Site | Google Scholar
  30. A. Gómez-Robles, W. D. Hopkins, and C. C. Sherwood, “Increased morphological asymmetry, evolvability and plasticity in human brain evolution,” Proceedings of the Royal Society B: Biological Science, vol. 280, no. 1761, article 20130575, 2013. View at: Publisher Site | Google Scholar
  31. K. J. Plessen, K. Hugdahl, R. Bansal, X. Hao, and B. S. Peterson, “Sex, age, and cognitive correlates of asymmetries in thickness of the cortical mantle across the life span,” The Journal of Neuroscience, vol. 34, no. 18, pp. 6294–6302, 2014. View at: Publisher Site | Google Scholar
  32. S. H. Ferris and M. Farlow, “Language impairment in Alzheimer’s disease and benefits of acetylcholinesterase inhibitors,” Clinical Interventions in Aging, vol. 8, pp. 1007–1014, 2013. View at: Publisher Site | Google Scholar
  33. C. A. Gold and A. E. Budson, “Memory loss in Alzheimer’s disease: implications for development of therapeutics,” Expert Review of Neurotherapeutics, vol. 8, no. 12, pp. 1879–1891, 2008. View at: Publisher Site | Google Scholar
  34. R. J. Killiany, T. Gomez-Isla, M. Moss et al., “Use of structural magnetic resonance imaging to predict who will get Alzheimer’s disease,” Annals of Neurology, vol. 47, no. 4, pp. 430–439, 2000. View at: Publisher Site | Google Scholar
  35. E. Goldberg, D. Roediger, N. E. Kucukboyaci et al., “Hemispheric asymmetries of cortical volume in the human brain,” Cortex, vol. 49, no. 1, pp. 200–210, 2013. View at: Publisher Site | Google Scholar
  36. L. deToledo-Morrell, T. R. Stoub, M. Bulgakova et al., “MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD,” Neurobiology of Aging, vol. 25, no. 9, pp. 1197–1203, 2004. View at: Publisher Site | Google Scholar
  37. S. Das, J. Pluta, L. Mancuso, D. Kliot, P. Yushkevich, and D. A. Wolk, “Involvement of anterior and posterior medial temporal lobe networks in early Alzheimer’s disease,” Alzheimer's & Dementia, vol. 10, no. 4, article P822, 2014. View at: Publisher Site | Google Scholar
  38. P. J. Visser, F. R. Verhey, P. A. Hofman, P. Scheltens, and J. Jolles, “Medial temporal lobe atrophy predicts Alzheimer’s disease in patients with minor cognitive impairment,” Journal of Neurology, Neurosurgery, & Psychiatry, vol. 72, no. 4, pp. 491–497, 2002. View at: Google Scholar
  39. L. R. Squire, C. E. Stark, and R. E. Clark, “The medial temporal lobe,” Annual Review of Neuroscience, vol. 27, no. 1, pp. 279–306, 2004. View at: Publisher Site | Google Scholar
  40. G. A. Kerchner, J. D. Bernstein, M. C. Fenesy et al., “Shared vulnerability of two synaptically-connected medial temporal lobe areas to age and cognitive decline: a seven tesla magnetic resonance imaging study,” The Journal of Neuroscience, vol. 33, no. 42, pp. 16666–16672, 2013. View at: Publisher Site | Google Scholar

Copyright © 2018 Xiaojing Long et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Related articles

No related content is available yet for this article.
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

No related content is available yet for this article.

Article of the Year Award: Outstanding research contributions of 2021, as selected by our Chief Editors. Read the winning articles.